IGEProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Swiss trademark AMBEVAGEN was filed as Word mark on 09/27/2016 at the Swiss Federal Institute of Intellectual Property.
It was registered as a trademark on 01/10/2017.
The current status of the mark is "Trademark registered".
| Application date | September 27, 2016 |
| Publication date | January 10, 2017 |
| Entry date | January 10, 2017 |
| Expiration date | September 27, 2026 |
Trademark owner
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
US
Trademark representatives
Hofwiesenstrasse 349
8050 Zürich
CH
goods and services
5
Pharmazeutische Präparate; pharmazeutische Präparate zur Behandlung von Krebs; andere pharmazeutische Präparate, nämlich Biosimilars zur Behandlung von Krebs, und pharmazeutische Präparate und Biosimilars zur Behandlung von Störungen und Erkrankungen der Lunge, des Gehirns, sowie ovarialen, renalen und zervikalen Störungen und Erkrankungen
The designations have been translated automatically. Show translation
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| December 14, 2023 | 2023121405 | M90 | Change Representative |
| January 10, 2017 | 2017011005 | M00 | Registration |
| January 10, 2017 | 2017011005 | M00 | Registration |
ID: 121205052765